Championed by AbbVie, immuno-neurology player Alector maps $150M IPO
Endorsed by AbbVie, and under the leadership of Genentech veteran Arnon Rosenthal, San Francisco-based biotech Alector has charted a path toward a $150 million IPO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.